Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin‐1
European Journal of Clinical Investigation · 2024-02 · 54 (2)
DOI: 10.1111/eci.14110 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 14.10.2023. Verfasst von Marco Giuseppe Del Buono und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, R…. Hauptthemen laut MEDLINE: Myocarditis, Atherosclerosis, Pericarditis, Sarcoidosis. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 126 Literaturangaben.
Abstract (Originalsprache)
Background
An exuberant and dysregulated inflammatory response contributes to the development and progression of cardiovascular diseases (CVDs).
Methods
This narrative review includes original articles and reviews published over the past 20 years and found through PubMed. The following search terms (or combination of terms) were considered: “acute pericarditis,” “recurrent pericarditis,” “myocarditis,” “cardiac sarcoidosis,” “atherosclerosis,” “acute myocardial infarction,” “inflammation,” “NLRP3 inflammasome,” “Interleukin‐1” and “treatment.” Results Recent evidence supports the role of inflammation across a wide spectrum of CVDs including myocarditis, pericarditis, inflammatory cardiomyopathies (i.e. cardiac sarcoidosis) as well as atherosclerotic CVD and heart failure. Interleukins (ILs) are the signalling mediators of the inflammatory response. The NACHT, leucine‐rich repeat and pyrin‐domain containing protein 3 (NLRP3) inflammasome play a key role in producing IL‐1β, the prototypical pro‐inflammatory cytokine involved in CVDs. Other pro‐inflammatory cytokines (e.g. tumour necrosis factor) have been implicated in cardiac sarcoidosis. As a proof of this, IL‐1 blockade has been proven efficacious in pericarditis and chronic coronary syndrome.
Conclusion
Tailored strategies aiming at quenching the inflammatory response have emerged as promising to treat CVDs. In this review article, we summarize recent evidence regarding the role of inflammation across a broad spectrum of CVDs. We also review novel evidence regarding targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy.
- Department of Internal Medicine, Medical Center, S.C. Medicina Generale 1, Ospedale di Circolo and Fondazione Macchi, ASST Sette Laghi, Varese, Italy.
- Robert M. Berne Cardiovascular Research Center, Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, Virginia, USA.
- VCU Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
- Department of Medicine and Surgery, University of Insubria, Varese, Italy.
- Department of Cardiology, Policlinico Casilino, Rome, Italy.
ORCID-Profile: Aldo Bonaventura
Zitieren
APA
Del Buono, M. G., Bonaventura, A., Vecchié, A., Moroni, F., Golino, M., Bressi, E., De Ponti, R., Dentali, F., Montone, R. A., Kron, J., Lazzerini, P. E., Crea, F., & Abbate, A. (2024). Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin‐1. European Journal of Clinical Investigation, 54(2). https://doi.org/10.1111/eci.14110
Vancouver
Del Buono MG, Bonaventura A, Vecchié A, Moroni F, Golino M, Bressi E, et al. Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin‐1. European Journal of Clinical Investigation. 2024;54(2). doi:10.1111/eci.14110
BibTeX
@article{DelBuono2024,
author = {Del Buono, Marco Giuseppe and Bonaventura, Aldo and Vecchié, Alessandra and Moroni, Francesco and Golino, Michele and Bressi, Edoardo and De Ponti, Roberto and Dentali, Francesco and Montone, Rocco Antonio and Kron, Jordana and Lazzerini, Pietro Enea and Crea, Filippo and Abbate, Antonio},
title = {Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin‐1},
journal = {European Journal of Clinical Investigation},
year = {2024},
volume = {54},
number = {2},
doi = {10.1111/eci.14110}
}
EUVIMED